Abstract:AIM:To construct recombinant eukaryotic expression vectors pEGFP-C3-SNCA containing human wild-type (WT) and pathogenic mutations A30P, A53T alpha-synuclein (SNCA), and to obtain monoclonal PC12 cell lines overexpressing human wild-type and pathogenic mutations A30P, A53T alpha-synuclein by stable transfection.METHODS:Human wild type SNCA gene was cloned by using RT-PCR. By T-A extension cloning, the gene was ligated with T-vector and sequenced. Based on it, the recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its G88C (Ala30Pro) and G209A (Ala53Thr) pathogenic mutation were constructed by site-directed mutagensis using primer variance in mononucleotide. And different recombinant plasmids pEGFP-C3-SNCA were identified with PCR, restriction enzyme digestion and DNA sequencing. PC12 cells were transfected with different recombinant plasmids pEGFP-C3-SNCA by liposome transfection method, screened with G418, and subcloned by limited dilution method to obtain different monoclonal PC12 cell lines stably over-expressing human wild-type, A30P or A53T alpha-synuclein, respectively, and PC12 cells stably transfected with pEGFP-C3 were used as control group. These monoclonal PC12 cell lines were identified with RT-PCR, Western blot and fluorescence microscopy.RESULTS:According to result of PCR, the double digestion and gene sequencing, it was comfirmed that recombinant eukaryotic expression vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutation had been constructed successfully. By means of RT-PCR, Western blot and fluorescence microscope, it was comfirmed that objective gene sequences in PC12 cells were stably over-expressed.CONCLUSION:The recombinant pEGFP-C3-SNCA vectors containing wild type SNCA synonymous mutation or its Ala30Pro and Ala53Thr pathogenic mutations had been constructed successfully. The transfected monoclonal PC12 cells are obtained in which three SNCA gene isoforms had stable expression.

Construction of SCN3A gene mutant expression vector andits expression in HEK 293 cells

Expression of Sodium Channel Overlap Syndrome SCN5A Gene in H9C2 Cell

Site-directed Mutagenesis and Protein Expression of SCN5A Gene Associated with Congenital Long QT Syndrome

[Construction of Eukaryotic Expression Vector Containing Hsnca Gene and Its Pathogenic Mutants and Its Expression in PC12 Cells].

Construction and Identification of the Recombinant Lentiviral Vector Expressing Human Neurotrophin-3 Gene

CONSTRUCTION OF A RECOMBINANT ADENOVIRUS VECTOR, EXPRESSION OF HUMAN NEUROTROPHIN-3 WITH BIOLOGICAL ACTIVITY

Construction and identification of eukaryotic expression vector for mutant PCNA

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

Construction and Identification of Eukaryotic Expressed Plasmid Vector Plenti6/v5- DEST-Cx43 in Human

Cloning and Eukaryotic Expression Vectors Construction of Wild Type and Truncated Mouse Ciliary Neurotrophic Factor Gene

Construction and characterization of human SUMO3 mutant (SUMO3-K11R) eukaryotic expression vector

Construction of eukaryotic expression vector of rat HAS-3 gene and its effects on chemotaxis]

Construction and expression of mutate plasmid CMV-3flag-hPROKR2(343YFK/AAA345,351 HWR/AAA353)

Construction of eukaryotic vector of human sTNFR1

[Site-Directed Mutagenesis and Protein Expression of ABCA3 Gene in A549 Cells].

Construction of eukaryotic plasmid including HCV NS3 gene and expression of NS3 protein in cells of HeLa

Construction and Expression of Eukaryotic Expression Vector Plc3-Egfp

Amplification of Human Neurotrophin-3 Recepter Gene and Construction of Recombinant Adenovirus Expression Vector for TrkC

Site-directed Mutagenesis of Long QT Syndrome KCNQ1 Gene in Vitro

Transfection of Adenovirus-mediated Neurotrophin-3 Gene into Schwann Cells

Construction of Eukaryotic Expression Vector with a Site-directed Mutation of Porcine MSTN Propeptide Gene and Its Expression in C2C12 Cells